General Atomics: Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test
General Atomics: Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced March 30th that it has obtained CE-IVD marking for its SARS-CoV-2 neutralizing antibody test. The Diazyme test is a high throughput chemiluminescent immunoassay with excellent correlation to a fluorescence based neutralization assay, which has been used to evaluate the adaptive immune respo...
United States Rw Frenck Jr Emile Dergham Abhijit Datta Journal Of Applied Laboratory Medicine Diazyme Laboratories Inc
Source: finanznachrichten.de